Insider · CIK 0000315066
FMR LLC
Files at: GPCR, BEAM, VRAY, YARW, SURF, DNLI, COGT, DMTX and 8 more. On EDGAR ↗
Reported trades — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 25, 2026 SForm 4 → | Jun 29, 2:17 pm EDT | Beam Therapeutics Inc.BEAM | 284,860 | $35.24 | $10,039,492 | 854,583 | −25.0% | |
| Aug 8, 2018 SForm 4 → | Aug 10, 2:30 pm EDT | ViewRay, Inc.VRAY | 200,000 | $10.02 | $2,004,000 | 604,736 | −24.9% | plan? |
| Aug 6, 2018 SForm 4 → | Aug 8, 2:17 pm EDT | ViewRay, Inc.VRAY | 173,929 | $10.48 | $1,822,833 | 804,736 | −17.8% | plan? |
| Aug 2, 2018 SForm 4 → | Aug 6, 5:15 pm EDT | ViewRay, Inc.VRAY | 334,675 | $11.44 | $3,829,716 | 978,665 | −25.5% | plan? |
| Jul 31, 2018 SForm 4 → | Aug 2, 3:29 pm EDT | ViewRay, Inc.VRAY | 127,206 | $12.07 | $1,535,671 | 1,313,340 | −8.83% | plan? |
| Jul 27, 2018 SForm 4 → | Jul 31, 3:09 pm EDT | ViewRay, Inc.VRAY | 258,565 | $11.51 | $2,975,704 | 1,440,546 | −15.2% | plan? |
| Jul 25, 2018 SForm 4 → | Jul 27, 2:22 pm EDT | ViewRay, Inc.VRAY | 295,850 | $12.08 | $3,573,071 | 1,699,111 | −14.8% | plan? |
| Apr 23, 2018 CForm 4 → | Apr 25, 3:53 pm EDT | Surface Oncology, Inc.SURF | 1,888,986 | — | — | 1,888,986 | — | plan? |
| Apr 3, 2018 PForm 4 → | Apr 5, 12:27 pm EDT | Unum Therapeutics Inc.UMRX | 94,052 | $12.00 | $1,128,624 | 452,115 | +26.3% | plan? |
| Apr 3, 2018 CForm 4 → | Apr 5, 12:27 pm EDT | Unum Therapeutics Inc.UMRX | 2,318,538 | — | — | 23,240 | — | plan? |
| Jan 29, 2018 CForm 4 → | Jan 31, 4:31 pm EST | Menlo Therapeutics, Inc.MNLO | 1,118,054 | — | — | 1,118,054 | — | plan? amended |
| Dec 12, 2017 CForm 4 → | Dec 14, 3:05 pm EST | Denali Therapeutics Inc.DNLI | 3,238,676 | — | — | 33,215 | — | plan? |
| Nov 7, 2017 UForm 4 → | Nov 9, 5:01 pm EST | Dimension Therapeutics, Inc.DMTX | 4,893,322 | $6.00 | $29,359,932 | 0 | — | plan? |
| Jul 3, 2017 CForm 4 → | Jul 6, 10:41 am EDT | Mersana Therapeutics, Inc.MRSN | 1,329,981 | — | — | 1,329,981 | — | plan? |
| Apr 25, 2017 SForm 4 → | Apr 27, 10:23 am EDT | ViewRay, Inc.VRAY | 106,781 | $6.76 | $722,372 | 5,499,447 | −1.90% | plan? |
| Apr 21, 2017 SForm 4 → | Apr 25, 12:32 pm EDT | ViewRay, Inc.VRAY | 101,139 | $6.71 | $678,334 | 5,606,228 | −1.77% | plan? |
| Apr 19, 2017 SForm 4 → | Apr 21, 4:11 pm EDT | ViewRay, Inc.VRAY | 101,236 | $6.90 | $698,113 | 5,707,367 | −1.74% | plan? |
| Apr 17, 2017 SForm 4 → | Apr 19, 3:52 pm EDT | ViewRay, Inc.VRAY | 107,217 | $7.24 | $776,226 | 5,808,603 | −1.81% | plan? |
| Apr 13, 2017 SForm 4 → | Apr 17, 2:37 pm EDT | ViewRay, Inc.VRAY | 115,860 | $7.44 | $861,677 | 5,915,820 | −1.92% | plan? |
| Apr 11, 2017 SForm 4 → | Apr 13, 3:11 pm EDT | ViewRay, Inc.VRAY | 179,494 | $7.40 | $1,328,901 | 6,031,680 | −2.89% | plan? |
| Apr 10, 2017 SForm 4 → | Apr 11, 4:38 pm EDT | ViewRay, Inc.VRAY | 178,556 | $7.77 | $1,387,997 | 6,211,174 | −2.79% | plan? |
| Apr 6, 2017 SForm 4 → | Apr 10, 2:32 pm EDT | ViewRay, Inc.VRAY | 52,050 | $7.89 | $410,845 | 6,389,730 | −0.81% | plan? |
| Apr 4, 2017 SForm 4 → | Apr 6, 4:07 pm EDT | ViewRay, Inc.VRAY | 196,397 | $7.90 | $1,551,812 | 6,441,780 | −2.96% | plan? |
| Mar 31, 2017 SForm 4 → | Apr 4, 4:07 pm EDT | ViewRay, Inc.VRAY | 217,883 | $8.29 | $1,807,283 | 6,638,177 | −3.18% | plan? |
| Mar 30, 2017 SForm 4 → | Apr 3, 5:47 pm EDT | ViewRay, Inc.VRAY | 28,661 | $8.46 | $242,472 | 6,856,060 | −0.42% | plan? |
| Mar 29, 2017 JForm 4 → | Mar 30, 5:05 pm EDT | ViewRay, Inc.VRAY | 1,105,202 | — | — | 6,884,721 | — | plan? |
| Mar 13, 2017 SForm 4 → | Mar 15, 4:17 pm EDT | PROTEOSTASIS THERAPEUTICS, INC.PTI | 25,000 | $12.94 | $323,500 | 243,508 | −9.31% | plan? |
| Mar 10, 2017 SForm 4 → | Mar 13, 5:17 pm EDT | PROTEOSTASIS THERAPEUTICS, INC.PTI | 25,000 | $12.04 | $301,000 | 268,508 | −8.52% | plan? |
| Mar 8, 2017 SForm 4 → | Mar 10, 3:36 pm EST | PROTEOSTASIS THERAPEUTICS, INC.PTI | 29,300 | $12.08 | $353,857 | 293,508 | −9.08% | plan? |
| Mar 6, 2017 SForm 4 → | Mar 8, 3:33 pm EST | PROTEOSTASIS THERAPEUTICS, INC.PTI | 60,000 | $13.01 | $780,705 | 322,808 | −15.7% | plan? |
| Mar 2, 2017 SForm 4 → | Mar 6, 6:05 pm EST | PROTEOSTASIS THERAPEUTICS, INC.PTI | 45,000 | $13.91 | $625,825 | 382,808 | −10.5% | plan? |
| Feb 28, 2017 SForm 4 → | Mar 2, 4:14 pm EST | PROTEOSTASIS THERAPEUTICS, INC.PTI | 45,000 | $14.62 | $658,050 | 427,808 | −9.52% | plan? |
| Feb 24, 2017 SForm 4 → | Feb 28, 4:34 pm EST | PROTEOSTASIS THERAPEUTICS, INC.PTI | 28,000 | $14.60 | $408,900 | 472,808 | −5.59% | plan? |
| Dec 19, 2016 JForm 4 → | Dec 21, 10:58 am EST | Aclaris Therapeutics, Inc.ACRS | 639,627 | — | — | 1,931,727 | — | plan? |
| Oct 26, 2016 SForm 4 → | Oct 28, 3:39 pm EDT | Aclaris Therapeutics, Inc.ACRS | 3,750 | $21.94 | $82,260 | 2,571,354 | −0.15% | plan? |
| Oct 19, 2016 JForm 4 → | Oct 20, 4:20 pm EDT | Aclaris Therapeutics, Inc.ACRS | 84,223 | — | — | 2,575,104 | — | plan? |
| Sep 30, 2016 GForm 4 → | Oct 11, 12:25 pm EDT | EXA CORPEXA | 2,105,642 | — | — | 0 | — | plan? late |
| Aug 30, 2016 JForm 4 → | Aug 31, 11:09 am EDT | Aclaris Therapeutics, Inc.ACRS | 130,571 | — | — | 2,659,327 | — | plan? |
| Aug 8, 2016 SForm 4 → | Aug 10, 2:39 pm EDT | Coherus BioSciences, Inc.CHRS | 100,000 | $29.86 | $2,986,216 | 361,594 | −21.7% | plan? |
| Aug 4, 2016 SForm 4 → | Aug 8, 5:29 pm EDT | Coherus BioSciences, Inc.CHRS | 48,600 | $28.48 | $1,383,988 | 461,594 | −9.53% | plan? |
| May 17, 2016 JForm 4 → | May 18, 4:54 pm EDT | REGENXBIO Inc.RGNX | 129,496 | — | — | 489,880 | — | plan? |
| May 17, 2016 SForm 4 → | May 18, 4:54 pm EDT | REGENXBIO Inc.RGNX | 18,300 | $12.41 | $227,103 | 619,376 | −2.87% | plan? |
| May 13, 2016 SForm 4 → | May 17, 1:46 pm EDT | REGENXBIO Inc.RGNX | 16,030 | $11.65 | $186,765 | 637,676 | −2.45% | plan? |
| May 12, 2016 SForm 4 → | May 13, 3:00 pm EDT | REGENXBIO Inc.RGNX | 6,711 | $10.85 | $72,833 | 653,706 | −1.02% | plan? |
| May 10, 2016 SForm 4 → | May 12, 2:46 pm EDT | REGENXBIO Inc.RGNX | 25,132 | $10.36 | $260,453 | 660,417 | −3.67% | plan? |
| May 6, 2016 SForm 4 → | May 10, 2:06 pm EDT | REGENXBIO Inc.RGNX | 10,570 | $9.94 | $105,087 | 685,549 | −1.52% | plan? |
| May 4, 2016 SForm 4 → | May 6, 3:17 pm EDT | REGENXBIO Inc.RGNX | 1,896 | $10.51 | $19,919 | 696,119 | −0.27% | plan? |
| May 2, 2016 SForm 4 → | May 4, 12:15 pm EDT | REGENXBIO Inc.RGNX | 6,046 | $10.76 | $65,066 | 698,015 | −0.86% | plan? |
| May 2, 2016 JForm 4 → | May 3, 2:56 pm EDT | Dimension Therapeutics, Inc.DMTX | 2,106,784 | — | — | 4,893,322 | — | plan? |
| Apr 29, 2016 SForm 4 → | May 2, 3:24 pm EDT | REGENXBIO Inc.RGNX | 4,723 | $10.80 | $51,020 | 704,061 | −0.67% | plan? |
| Apr 27, 2016 SForm 4 → | Apr 29, 1:11 pm EDT | REGENXBIO Inc.RGNX | 33,196 | $11.23 | $372,703 | 708,784 | −4.47% | plan? |
| Apr 25, 2016 SForm 4 → | Apr 27, 4:17 pm EDT | REGENXBIO Inc.RGNX | 9,188 | $11.19 | $102,832 | 741,980 | −1.22% | plan? |
| Apr 21, 2016 SForm 4 → | Apr 25, 4:02 pm EDT | REGENXBIO Inc.RGNX | 20,558 | $11.30 | $232,241 | 751,168 | −2.66% | plan? |
| Apr 19, 2016 JForm 4 → | Apr 21, 2:28 pm EDT | Aclaris Therapeutics, Inc.ACRS | 1,014,381 | — | — | 2,789,898 | — | plan? |
| Apr 19, 2016 SForm 4 → | Apr 21, 2:03 pm EDT | REGENXBIO Inc.RGNX | 13,189 | $11.66 | $153,765 | 771,726 | −1.68% | plan? |
| Apr 15, 2016 SForm 4 → | Apr 19, 3:56 pm EDT | REGENXBIO Inc.RGNX | 18,900 | $11.75 | $222,132 | 784,915 | −2.35% | plan? |
| Apr 12, 2016 SForm 4 → | Apr 15, 4:15 pm EDT | REGENXBIO Inc.RGNX | 27,036 | $11.46 | $309,907 | 803,815 | −3.25% | plan? late |
| Mar 17, 2016 JForm 4 → | Mar 18, 4:35 pm EDT | REGENXBIO Inc.RGNX | 254,965 | — | — | 830,851 | — | plan? |
| Feb 17, 2016 PForm 4 → | Feb 18, 2:00 pm EST | PROTEOSTASIS THERAPEUTICS, INC.PTI | 375,000 | $8.00 | $3,000,000 | 1,877,812 | +25.0% | plan? |
| Feb 17, 2016 CForm 4 → | Feb 18, 2:00 pm EST | PROTEOSTASIS THERAPEUTICS, INC.PTI | 1,108,931 | — | — | 1,502,812 | — | plan? |
| Nov 25, 2015 SForm 4 → | Nov 30, 2:32 pm EST | Blueprint Medicines CorpBPMC | 287,415 | $21.48 | $6,173,437 | 264,898 | −52.0% | plan? |
| Nov 24, 2015 SForm 4 → | Nov 25, 10:49 am EST | Blueprint Medicines CorpBPMC | 161,271 | $20.14 | $3,247,998 | 552,313 | −22.6% | plan? |
| Nov 20, 2015 SForm 4 → | Nov 23, 6:12 pm EST | Blueprint Medicines CorpBPMC | 189,572 | $20.15 | $3,820,453 | 713,584 | −21.0% | plan? |
| Nov 18, 2015 SForm 4 → | Nov 20, 3:07 pm EST | Blueprint Medicines CorpBPMC | 237,218 | $19.76 | $4,688,485 | 903,156 | −20.8% | plan? |
| Nov 17, 2015 SForm 4 → | Nov 19, 1:36 pm EST | Blueprint Medicines CorpBPMC | 27,490 | $20.60 | $566,220 | 1,140,374 | −2.35% | plan? |
| Nov 16, 2015 GForm 4 → | Nov 19, 1:36 pm EST | Blueprint Medicines CorpBPMC | 733 | — | — | 1,167,864 | — | plan? late |
| Nov 16, 2015 SForm 4 → | Nov 18, 11:29 am EST | Blueprint Medicines CorpBPMC | 28,684 | $20.83 | $597,544 | 1,168,597 | −2.40% | plan? |
| Nov 13, 2015 GJForm 4 → | Nov 17, 1:57 pm EST | Blueprint Medicines CorpBPMC | 1,303,430 | — | — | 1,197,281 | — | plan? |
| Oct 27, 2015 CForm 4 → | Oct 29, 9:28 am EDT | Dimension Therapeutics, Inc.DMTX | 6,760,627 | — | — | 7,000,106 | — | plan? |
| Oct 13, 2015 PForm 4 → | Oct 14, 2:40 pm EDT | Aclaris Therapeutics, Inc.ACRS | 335,455 | $11.00 | $3,690,005 | 3,804,279 | +9.67% | plan? |
| Oct 13, 2015 CForm 4 → | Oct 14, 2:40 pm EDT | Aclaris Therapeutics, Inc.ACRS | 3,468,824 | — | — | 3,468,824 | — | plan? |
| May 5, 2015 PForm 4 → | May 7, 4:49 pm EDT | Blueprint Medicines CorpBPMC | 125,000 | $18.00 | $2,250,000 | 2,500,711 | +5.26% | plan? |
| May 5, 2015 CForm 4 → | May 7, 4:49 pm EDT | Blueprint Medicines CorpBPMC | 2,375,711 | — | — | 2,375,711 | — | plan? |
| Mar 5, 2015 GForm 4 → | Mar 9, 2:40 pm EDT | TETRAPHASE PHARMACEUTICALS INCTTPH | 671,912 | — | — | 0 | — | plan? |
Reported trades — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 22, 2026 SForm 4 → | Jul 24, 9:11 am EDT | Structure Therapeutics Inc.GPCR | 17,452 | $50.07 | $873,822 | 16,086 | — | |
| Apr 23, 2018 CForm 4 → | Apr 25, 3:53 pm EDT | Surface Oncology, Inc.SURF | 4,155,773 | — | — | 0 | — | |
| Apr 3, 2018 CForm 4 → | Apr 5, 12:27 pm EDT | Unum Therapeutics Inc.UMRX | 3,640,413 | — | — | 0 | — | |
| Jan 29, 2018 CForm 4 → | Jan 31, 4:31 pm EST | Menlo Therapeutics, Inc.MNLO | 3,015,953 | — | — | 0 | — | amended |
| Dec 12, 2017 CForm 4 → | Dec 14, 3:05 pm EST | Denali Therapeutics Inc.DNLI | 3,238,676 | — | — | 0 | — | |
| Jul 3, 2017 CForm 4 → | Jul 6, 10:41 am EDT | Mersana Therapeutics, Inc.MRSN | 1,329,981 | — | — | 0 | — | |
| Feb 17, 2016 CForm 4 → | Feb 18, 2:00 pm EST | PROTEOSTASIS THERAPEUTICS, INC.PTI | 11,987,782 | — | — | 0 | — | |
| Oct 27, 2015 CForm 4 → | Oct 29, 9:28 am EDT | Dimension Therapeutics, Inc.DMTX | 19,761,313 | — | — | 0 | — | |
| Oct 13, 2015 CForm 4 → | Oct 14, 2:40 pm EDT | Aclaris Therapeutics, Inc.ACRS | 11,967,446 | — | — | 0 | — | |
| May 5, 2015 CForm 4 → | May 7, 4:49 pm EDT | Blueprint Medicines CorpBPMC | 13,066,425 | — | — | 0 | — |